{
    "nctId": "NCT06347354",
    "briefTitle": "Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes",
    "officialTitle": "Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Braast Cancer and Metastatic Lymph Nodes (FLUO)",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Permanence of fluorescence at the level of axillary lymph nodes at 2-3 weeks after subcutaneous injection of Indocyanine Green (2.5 mg), in patients who will undergo radical axillary surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written informed consent must be obtained and documented before starting protocol-specific procedures and follow-up, according to local regulatory requirements.\n* \\>18 years old\n* Breast cancer patients with cyto-histologically ascertained lymph node metastases and candidates for quadrantectomy/mastectomy combined with radical axillary surgery\n\nExclusion Criteria:\n\n* patients allergic to Iodine or Indocyanine Green\n* patients with thyroid diseases (hyperthyroidism, autoimmune thyroid adenomas)\n* patients who are not candidates for radical axillary surgery\n* pregnant patients\n* underage patients\n* interdicted patients or patients requiring a support administrator",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}